Prof. Dr. Bertram Häussler


IGES Institut

Prof. Dr. Bertram Häussler is the chairman of the IGES Institut. He is a physician, sociologist and honorary professor for economics of the pharmaceutical industry at the Technical University (TU) Berlin. His research focuses on health economics, health technology assessment in a national and international context, and the digitalization of the health care system. He is one of the most recognized specialists in the field of health economics. His particular research area in the area of digitalization is on real world evidence as well as health services research. 

Dr. Marc Kurepkat

Managing Director

Dr. Marc Kurepkat is a physician specializing in general medicine and managing director of CSG Clinische Studien Gesellschaft mbH (CSG). He studied medicine at the Free University of Berlin. Residency in internal medicine with focus on gastroenterology, geriatrics and emergency medicine. Many years of experience in leading positions in the health care sector. Has held various positions within the IGES Group since 2001 (clinical research, care management, digitalization). Marc Kurepkat also runs a general medical care center and psychotherapy practices. He has extensive experience in managing studies and supporting market access for the medical device industry.

Michael Weisser

Managing Director


Mr. Weisser holds a Master equivalent degree in Economics from the Albert Ludwig University of Freiburg (i. Brsg.). He is a recognized expert for market access and reimbursement, particularly for the medical device sector and digital health solutions. His work also comprises the reimbursement of diagnostic and therapeutic procedures that are based on the use of medical devices and digital therapeutics. This involves the research, processing and analysis of circumstances in various health and insurance systems in the European and German context and the subsequent derivation of market access strategies. In addition, Mr. Weisser plans and holds international workshops as well as conference contributions related to reimbursement and market access for Germany.

If required, further experts of the IGES Group from the fields of clinical trials, pharmaceutical markets, biometrics, statistics and biometrics as well as IT can be consulted. In addition, our experts in France and the United Kingdom are available to provide advice for these countries. 

Digital Health Apps in Germany

Market Access and Reimbursement for Digital Health Apps in Germany
New, expanded edition with additional information on digital nursing care apps.
Learn more with our 36 paged guide.

If you would like to order the guide, please write an email to Ms. Agata Daroszewska.

Digital Health Apps in Germany